Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Localised Prostate Carcinoma”

168 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 168 results

Very early researchStudy completedNCT04301414
What this trial is testing

Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 26
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Large-scale testing (Phase 3)UnknownNCT00003734
What this trial is testing

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
St. Luke's Hospital, Ireland 276
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)WithdrawnNCT03035357
What this trial is testing

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Who this might be right for
Malignant Neoplasms of Male Genital OrgansProstate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00924807
What this trial is testing

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Medical Center 4
Not applicableStudy completedNCT02618161
What this trial is testing

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Who this might be right for
Prostate Cancer
Mid and South Essex NHS Foundation Trust 100
Testing effectiveness (Phase 2)Study completedNCT01250717
What this trial is testing

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 28
Early research (Phase 1)Study completedNCT02111187
What this trial is testing

A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 14
Not applicableLooking for participantsNCT07222436
What this trial is testing

Circulating Tumor DNA in High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Pittsburgh 24
Not applicableActive Not RecruitingNCT02766543
What this trial is testing

Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Profound Medical Inc. 150
Not applicableStudy completedNCT04602208
What this trial is testing

FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR PRIMARY LOCALIZED PROSTATE CANCER: MIDTERM ONCOLOGICAL OUTCOMES

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 146
Not applicableActive Not RecruitingNCT02960087
What this trial is testing

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Who this might be right for
Prostate Carcinoma
Canadian Cancer Trials Group 334
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07455903
What this trial is testing

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Baptist Health South Florida 50
Testing effectiveness (Phase 2)Study completedNCT00500110
What this trial is testing

Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT02064582
What this trial is testing

Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 7
Not applicableUnknownNCT00573586
What this trial is testing

Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada

Who this might be right for
Prostate Cancer
SonaCare Medical 20
Testing effectiveness (Phase 2)WithdrawnNCT04569461
What this trial is testing

Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)

Who this might be right for
Prostate Cancer
Duke University
Testing effectiveness (Phase 2)UnknownNCT03432780
What this trial is testing

Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer Stage IIIProstate Cancer Stage IV
Spanish Oncology Genito-Urinary Group 134
Load More Results